The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome

Vaccine. 2003 Jun 20;21(21-22):2708-19. doi: 10.1016/s0264-410x(03)00229-9.

Abstract

In many developing countries, Measles-Mumps-Rubella (MMR) vaccine is available through the private but not the public sectors, and there is no systematic rubella vaccination among adult women. In this paper, we extend previous modeling studies to demonstrate that in developing countries with a medium-high force of infection (200-400/1000 per year), current levels of private sector MMR coverage (<60%) would lead to increases in the incidence of Congenital Rubella Syndrome (CRS) both among unvaccinated individuals and the general population even when mixing between vaccinated and unvaccinated individuals is fairly minimal. Our findings highlight the need for countries to establish surveillance of trends in susceptibility to rubella and CRS incidence and perhaps introduce rubella vaccination among women of child-bearing age.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Developing Countries
  • Female
  • Humans
  • Immunization Programs
  • Male
  • Measles-Mumps-Rubella Vaccine / therapeutic use*
  • Private Sector
  • Rubella Syndrome, Congenital / epidemiology
  • Rubella Syndrome, Congenital / prevention & control*
  • Time Factors
  • Vaccination

Substances

  • Measles-Mumps-Rubella Vaccine